Philadelphia will no longer be able to call itself one of the American headquarters of British drugmaker GlaxoSmithKline PLC, the company announced today.
Philadelphia will no longer be able to call itself one of the American headquarters of British drugmaker GlaxoSmithKline PLC, the company announced today.